Evidence map›Paper›PMID 11179427›Full record

ArticleMolecular biology of the cell2001

Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors.

H Peng, J Moffett, J Myers, X Fang, E K Stachowiak, P Maher, E Kratz, J Hines, S J Fluharty, E Mizukoshi and 2 more

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ERClinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  4. Article
  5. Review
  6. Article
  7. Angiotensin II increases angiogenesis by NF-κB-mediated transcriptional activation of angiogenic factor AGGF1.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2014
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

H PengMolecular and Structural Neurobiology and Gene Therapy Program, State University of New York, Buffalo, New York 14214, USA.
J Moffett
J Myers
X Fang
E K Stachowiak
P Maher
E Kratz
J Hines
S J Fluharty
E Mizukoshi
D C Bloom
M K Stachowiak
Arizona State University · USUniversity of Pennsylvania · USScripps Research Institute · US

Funding

STROKE THERAPY MECHANISMS WITH NEUROTROPHIC FACTORSP01NS028121 · NINDS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI ZIVIN, JUSTIN A. · 1990 to 2004
$6.4M
ANGIOTENSIN REGULATION OF GENE EXPRESSIONR01HL049376 · NHLBI · ST. JOSEPH'S HOSP/MED CTR (PHOENIX) · PI STACHOWIAK, MICHAL · 1993 to 2000
$278k
NHLBI NIH HHS HL-49376NHLBI NIH HHS R01 HL049376NINDS NIH HHS NS-28121NINDS NIH HHS P01 NS028121
6 · The paper itself

Abstract

In bovine adrenal medullary cells synergistically acting type 1 and type 2 angiotensin II (AII) receptors activate the fibroblast growth factor-2 (FGF-2) gene through a unique AII-responsive promoter element. Both the type 1 and type 2 AII receptors and the downstream cyclic adenosine 1',3'-monophosphate- and protein kinase C-dependent signaling pathways activate the FGF-2 promoter through a novel signal-transducing mechanism. This mechanism, which we have named integrative nuclear FGF receptor-1 signaling, involves the nuclear translocation of FGF receptor-1 and its subsequent transactivation of the AII-responsive element in the FGF-2 promoter.

Indexed as

Signal TransductionAdrenal MedullaAngiotensin IIAnimalsBinding SitesCattleCell NucleusCells, CulturedDeoxyribonuclease IDNA FootprintingFibroblast Growth Factor 2Gene Expression RegulationImidazolesPromoter Regions, GeneticPyridinesReceptor, Angiotensin, Type 1Angiotensin IIangiotensin II, Sar(1)-Deoxyribonuclease IFibroblast Growth Factor 2ImidazolesPD 123319PyridinesReceptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2Receptors, AngiotensinRecombinant ProteinsTrans-ActivatorsTyrosine

Identifiers

PMID11179427
PMCPMC30955
OpenAlexW2162279304

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.